propofol and lidocaine

PreclinicalSmall molecule

BBeijing Friendship Hospital

propofol and lidocaine is one of 3 small molecule programs targeting Esketamine. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

EsketamineUnknown status

EsketaminePreclinical

Unknown status

Competition

Competitive Landscape

2 competitors in Esketamine

#DrugCompanyPhaseTrials

Esketamine Hydrochloride

TThe Second Hospital of Anhui Medical University

Phase 3

2 2

Ayahuasca

UUniversity of Sao Paulo

Phase 2

3 3

propofol and lidocaine

BBeijing Friendship Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Esketamine1 trial

Comparison of the Effects of Esketamine, Sufentanil, or Lidocaine on Tussis Reflection During Upper Gastroscopy

Unknown status·—·N/A·NCT05497492·400 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for propofol and lidocaine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — propofol and lidocaine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for propofol and lidocaine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Beijing Friendship Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: BBeijing Friendship Hospital

propofol and lidocaine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Esketamine1 trial

References

Drug Info

Quick Facts

Related News